Healthcare - Biotechnology - NASDAQ - GB
$ 3.08
2.33 %
$ 896 M
Market Cap
-2.7
P/E
INCOME STATEMENT
1.7 M
REVENUE
-195 M
OPERATING INCOME
-208 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Autolus Therapeutics plc
| Revenue | 1.7 M |
| Cost Of Revenue | 6.56 M |
| Gross Profit | -4.87 M |
| Operating Expenses | 197 M |
| Operating Income | -195 M |
| Other Expenses | 13.4 M |
| Net Income | -208 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Sep-2018 | Sep-2017 | Sep-2016 | Sep-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 1.7 | 6.2 | 2.3 | 0.2 | 2.9 | 1.0 | 1.7 | 1.2 | 94.1 K |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 6.6 | 137.2 | 128.7 | 134.9 | 4.6 | 48.3 | 1.0 | 0.5 | 0 |
| Gross Profit | (4.9) | (131.0) | (126.3) | (134.6) | (1.7) | (47.3) | 0.7 | 0.7 | 94.1 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 196.7 | 173.7 | 166.7 | 168.4 | 144.9 | 41.5 | 25.1 | 15.6 | 8.2 |
| Selling, General and Administrative Expenses | 46.7 | 31.9 | 31.9 | 35.0 | 39.5 | 16.8 | 9.1 | 5.2 | 6.0 |
| Research and Development Expenses | 150.0 | 142.0 | 134.8 | 134.9 | 105.4 | 24.6 | 16.0 | 10.4 | 2.2 |
| Operating Income | (195.0) | (163.8) | (164.2) | (168.1) | (137.9) | (57.5) | (23.4) | (14.4) | (8.1) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 45.1 | 8.9 | 1.1 | 0 | 0 | 12.7 K | 0 | 0 | 0 |
| Total Other Income | (13.4) | (9.4) | 109.2 | 1.9 | 3.0 | 6.9 | 38 K | 49 K | 7.93 K |
| Pre-Tax Income | (208.4) | (173.2) | (166.0) | (166.3) | (139.0) | (36.3) | (23.4) | (14.3) | (8.1) |
| NET INCOME | |||||||||
| Tax Provision | 19 K | (24.4) | (23.9) | (24.2) | (15.2) | (5.2) | (3.7) | (1.8) | 0.6 |
| Net Income | (208.4) | (148.8) | (142.1) | (142.1) | (123.8) | (31.1) | (19.7) | (12.6) | (7.5) |
| EPS | 1.2 | 1.57 | 1.97 | 2.76 | 2.88 | 0.99 | 1.43 | 0.91 | 0.542 |